Doylestown Health Joins Sidney Kimmel Cancer Network at Jefferson

18
Jan

The Sidney Kimmel Cancer Network at Jefferson and Doylestown Health will officially join forces effective January 1, 2017. The affiliation combines the expertise of a leading academic medical center and a community health system with a reputation for delivering quality health care.

As the newest member of the Sidney Kimmel Cancer Network (SKCN) at Jefferson, Doylestown Health will have enhanced access to research studies, medical education, cancer screenings and administrative resources at the Sidney Kimmel Cancer Center at Jefferson. In collaboration with their Doylestown Health physicians, patients will also have access to programs unique to the Sidney Kimmel Cancer Network at Jefferson, including Tele-Health, the Senior Adult Oncology Program and Precision Medicine, which includes advanced genetic analysis used in determining treatment courses. The affiliation means local access to medical expertise and advanced research for patients, unique to the Sidney Kimmel Cancer Network at Jefferson organization.

“We are thrilled to have the opportunity to join forces with our partners at Doylestown, working together to provide the most advanced cancer care for patients in the region,” shared Sidney Kimmel Cancer Center Director, Karen Knudsen, PhD. “We appreciate the importance and positive impact of being treated close to home. Through this partnership, we will expand options for patients battling cancer, from increased access to cutting-edge therapies to best of care plans available in our collective health systems.”

“Doylestown Health’s participation with Jefferson’s SKCN will provide our patients with even more resources, including access to clinical trials, expert second opinions and the latest information in the field of cancer genetics,” added Eileen Engle, MD, Medical Director of the oncology network for Doylestown Health.

“The relationship between Jefferson Health and Doylestown Hospital extends five years, when the hospital became a member of the Jefferson Neurosciences Network,” said Matthew Carabasi, MD, Senior Director of Strategic Oncology Partnerships at Jefferson Health. “Since that partnership, there have been other collaborations, both formal and informal, including strong clinical linkages among members of the Jefferson and Doylestown medical staffs for many years.”

“Doylestown Health’s continuous pursuit of excellence has earned us national recognition for the high quality and exceptional value we provide to our patients,” said Jim Brexler, President and CEO of Doylestown Health. “This new affiliation with the Sidney Kimmel Cancer Network expands the breadth of advanced medicine that the Doylestown Health Cancer Institute makes available to our patients close to home.”

The Sidney Kimmel Cancer Network was founded in 1993 with the mission to bring advanced treatments to patients through partnerships with outstanding health care institutions. The concept has further expanded to include helping partners, like Doylestown Health, provide the highest level of support for patients and their families at the time of diagnosis, during treatment and after recovery.

“Our commitment at Jefferson Health is to bring the very best in cancer care closer to a patient’s home,” said President and CEO of Thomas Jefferson University and Jefferson Health, Stephen Klasko, MD, MBA. “This unique partnership is transformative for communities that Doylestown Hospital serves so well, and allows patients and doctors to access all of the unique care and research from the Sidney Kimmel Cancer Center.”

“The Doylestown Health medical community has a long history of clinical integration to improve the health and wellness of the communities we serve,” said Scott Levy, MD, Vice President and Chief Medical Officer. “In partnership with Sidney Kimmel Cancer Network we look forward to building on our strong and successful oncology program with the additional resources and expertise augmented by Jefferson.”